Viatris announces launch of breyna™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first fda-approved generic version of symbicort® for people with asthma and chronic obstructive pulmonary disease, in partnership with kindeva

Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access pittsburgh and woodbury, minn., july 31, 2023 /prnewswire/ -- viatris inc. (nasdaq: vtrs), a global healthcare company, and kindeva drug delivery l.p.
VTRS Ratings Summary
VTRS Quant Ranking